I really don't want to be a doctor

Chapter 119 He's Really Just a Student (Part [-])
"Yes, I'm Hammer from Pfizer." Hammer explained patiently.

"Hello, Mr. Hammer, what can I do for you?" Jing Xiaoran said.

He was asking knowingly, and the other party was clearly here to acquire drug patents.

At this time, Jing Xiaoran must take the initiative. First of all, he must not be overwhelmed by the other party in terms of momentum, otherwise it will not be conducive to the subsequent negotiations.

"Mr. Jing, did you submit an article titled Development of new oral anticoagulants to "DRUG DISCOVERY TODAY" magazine before?" Hammer asked.

"Yes."

"Hehe, Mr. Jing, let me get straight to the point." Hammer said, "Do you have the molecular formula of the new oral anticoagulant drug?"

Jing Xiaoran smiled, but did not speak.

"It seems that Mr. Jing has acquiesced?" Hammer also laughed, "Then is the exclusive patent of this new drug also in your hands?"

There was silence for a moment.

Jing Xiaoran said slowly: "This is indeed a drug I developed, and I have also applied for an international patent."

"It seems that Mr. Jing is a sensible person, and I have found the right person." Harmer's hearty laughter came out again, "Mr. Jing, are you free tomorrow? I would like to meet with you to talk about the new Oral anticoagulant patents."

"Okay." Since the other party directly pointed it out, Jing Xiaoran readily agreed.

"That's really great, God bless. Tomorrow at ten o'clock in the morning, at Qingyun Hotel in Fancheng, I'm looking forward to Mr. Jing's arrival."

……

After hanging up the phone, Jing Xiaoran faintly felt excited that his thesis had finally attracted attention.

It seems that it is correct to submit an article to the "DRUG DISCOVERY TODAY" magazine. Even if the SCI impact factor is slightly lower, it can attract the attention of the editor.

This can attract the attention of international pharmaceutical companies like Pfizer.

If you submit to a journal like "The Lancet" again, and look at the author's affiliation and school, I am afraid that the editor will not read the paper carefully, let alone be discovered by a pharmaceutical company.

"In the previous life, the new oral anticoagulant was produced by Bayer." Jing Xiaoran thought, "So the brand name of the new oral anticoagulant is also called Xarelto, but now it is the pharmaceutical representative of Pfizer that came first."

But no matter which pharmaceutical company it is, it proves that Jing Xiaoran has already entered people's field of vision.

The first step of his plan, relying on "new oral anticoagulant drugs" to brush up his academic achievements, and then make a fortune by the way, has already succeeded for the most part.

"Ben Hamer of Pfizer..."

Jing Xiaoran didn't know this person, he didn't pay much attention to these pharmaceutical companies in his previous life, and he just entered the medical circle in this life.

Enter "Pfizer Ben Hamer" in the browser, and countless related information will immediately pop up.

"Ben Hamer, currently working for Pfizer, the head of Europe and the United States, one of the powerful figures in Pfizer..."

"Ben Hamer, who was the head of Pfizer's Asia-Pacific region, led a number of clinical studies and launched a number of new drugs in his hands."

"Hammer studied at the Department of Pharmacy at Harvard Medical School, and his mentor was Kingsley Coman, a world-renowned medical scientist. After graduation, he joined Pfizer..."

……

Jing Xiaoran didn't expect that Hamer had such a big background, that he was the general manager of the European and American regions. He thought that Hamer was just an ordinary employee of Pfizer's Huaxia region.

It seems that Pfizer really attaches great importance to the "new oral anticoagulant".

This is no wonder, after all, the net profit of this drug in the past life was billions of dollars a year.

At this time, in a star-rated restaurant with extremely gorgeous decoration in Fancheng.

Sitting in front of Hammer was a well-mannered middle-aged man. He wore gold-rimmed glasses and had a slight smile on his face.

If Jing Xiaoran was here, he would definitely recognize this man at a glance.

He is Li Qiuyu, a pediatric surgeon at Fancheng Children's Hospital!

"Dear Li, this really confirms what you Huaxia said."

"There is no place to find if you break through the iron shoes, and it takes no effort to get here." Hammer raised the wine glass in his hand and said with a smile, "I didn't expect you to know this Mr. Jing."

Hammer and Li Qiuyu have known each other since they were in the United States.

At that time, Hamer was just a small employee who had just joined Pfizer, and Li Qiuyu had just arrived in the United States. The two met in the experiment of Academician Wu Qiming.

As soon as they came and went, the two had a lot of intersection.

This time Hamer originally wanted to invite Li Qiuyu out to talk about the past, but when he talked about the purpose of this trip to China, he truthfully told Li Qiuyu.

He came to Ning'an Medical College in Fancheng to acquire patents.

When Li Qiuyu heard about the new oral anticoagulant mentioned by Hammer, and the author of this paper was still in Ning'an Medical College, Li Qiuyu immediately thought of Jing Xiaoran.

After some in-depth exchanges between the two, Li Qiuyu discovered that the person who published the paper was also surnamed Jing, so he told Hamer his conjecture.

"Hammer, I might know the Mr. Jing you mentioned!"

So there was the call from Hammer just now.

At this moment, Li Qiuyu was also shocked in her heart, she didn't expect it to be Jing Xiaoran.

No wonder he always wanted to go to the laboratory to do independent experiments.

But now it is less than two months before Jing Xiaoran enters the laboratory.

In such a short period of time, a new drug has been developed?
Li Qiuyu felt incredible, what kind of drug on the market now has not been developed after more than ten years and spent countless funds to succeed?

"Hammer, don't you doubt the authenticity of Jing Xiaoran's paper?" Li Qiuyu asked suspiciously, "His paper only wrote about the molecular mechanism of the new oral anticoagulant, and did not describe the molecular formula of the new drug in detail."

Upon hearing this, Hamer rubbed his chin with his hand, and said with a smile: "My dear Li, if I hadn't read the article written by Jing Xiaoran, I would have doubts."

"In fact, several pharmaceutical companies in the United States are researching new anticoagulant drugs, such as Bayer and AstraZeneca. To put it bluntly, we are engaged in a scientific research competition."

"I happen to have a project on new oral anticoagulant drugs in my hand, so when I read Mr. Jing's article, I can almost tell the truth from the fake. And I also checked, he is indeed an international applicant for new oral anticoagulant drugs patent."

Li Qiuyu nodded, this matter is probably true.

But until now, he still can't believe that that seemingly ordinary boy actually secretly developed a new drug!
"Hammer, you have personally come to China this time, and you can see that Pfizer attaches great importance to new oral anticoagulant drugs." Li Qiuyu said.

Hamer smiled: "Of course, several of our major pharmaceutical companies have started a scientific research competition. The profits that this drug can bring can be imagined. Once it passes the Phase 3 clinical trial, it will be great."

Li Qiuyu himself is a doctor in cardiovascular surgery, and he knows that once this new type of drug is on the market, it will gradually replace today's conventional anticoagulant drugs. It is widely used in surgery and cardiovascular and cerebrovascular fields, and the benefits it brings will definitely be huge.

"Li, thanks to you this time. If you wait until next Monday to go to Ning'an Medical College, you will inevitably waste time." Hammer continued.

"Hammer, I have to remind you." Li Qiuyu said, "Jing Xiaoran is just a freshman."

"Lee, what?"

Hammer stood up suddenly, and looked at Li Qiuyu with suspicion.

"He...is he still a student?"

Hamer held back the shock in his heart and sat down slowly.

"We, Pfizer, have dozens of senior drug researchers or engineers in this project, and have invested hundreds of millions of dollars so far. Can't this be compared to a Chinese student?"

"Li, you are the smartest and friendliest Chinese person I've ever met, you didn't lie to me?"

"It's true, he's really just a student."

　Please subscribe!

　　
　
(End of this chapter)